Search results

12 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Five genetic regions implicated in cystic fibrosis severity
An international consortium of researchers conducted the largest-ever CF genome-wide analysis to find new therapeutic targets.
Located in News / 2015 / September
Scientists find gene linked to heightened mucus levels in lung disease
In lab experiments, UNC School of Medicine researchers showed that blocking the gene Bpifb1 led to a striking increase in the mucin protein MUC5B in mucus.
Located in News / 2017 / October
Cystic Fibrosis Discovery: Bacterial Burden Begins During First Years of Life
UNC School of Medicine scientists show that therapies to break up mucus in toddlers might offer the best route to a longer life for CF patients.
Located in News / 2018 / January
Some e-cigarette ingredients are surprisingly more toxic than others
UNC School of Medicine scientists led by Robert Tarran created a new screening technique to deduce the different toxicity levels of the more than 7,700 types of e-liquid flavors available to consumers.
Located in News / 2018 / March
The Heart of a Researcher
At the UNC School of Medicine, researchers come to their work through various paths. For Wanda O'Neal, PhD, her tireless dedication to researching cystic fibrosis and lung conditions was born from a very personal place -- a family with six kids with CF.
Located in News / 2018 / May
Are e-cigarettes ‘safer’ than regular cigarettes?
UNC School of Medicine researchers lead new study showing that e-cigarettes trigger unique and potentially damaging immune responses in human airways.
Located in News / 2017 / October
UNC lung researchers awarded $12.5-million NIH grant to develop new drug compounds
The National Institutes of Health has awarded four UNC experts a translational program project grant (tPPG) to develop and test therapeutics aimed at reducing the hyper-concentration of mucus often found in cystic fibrosis and asthma patients.
Located in News / 2017 / September
New simple test could help cystic fibrosis patients find best treatment
In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique developed in the lab of Martina Gentzsch, PhD, shows promise as a fast, inexpensive indicator to help more patients access new treatments.
Located in News / 2017 / November
A New Test to Measure the Effectiveness of CF Drugs
A new lab model developed by UNC’s Carla Ribeiro, PhD, and colleagues can be used to test new therapeutics for cystic fibrosis.
Located in News / 2017 / November
CF Foundation honors UNC researchers for vital treatment
Hypertonic saline, developed into an effective treatment at UNC School of Medicine in collaboration with Australian researchers, has become a proven therapy for thousands of people with cystic fibrosis.
Located in News / 2014 / October